Analyst firms · Jefferies · TNGX
Jefferies TNGX price target and rating history
Tango Therapeutics Inc. (TNGX) · Health Care
Jefferies rates Tango Therapeutics Inc. (TNGX) Buy with a $60 price target, as of its latest action on Jun 26, 2026. It has published 3 rating actions on TNGX since July 2024, including 1 upgrade and 1 downgrade. Across 4 firms with a TNGX price target in the last 12 months, the median target is $27. Jefferies's $60 is 122% above that.
- Current rating
- Buy
- Price target
- $60
- Median target, all firms
- $27
- Actions on TNGX
- 3
Jefferies price target on TNGX
Every Jefferies rating on TNGX
- Jun 26, 2026
- May 14, 2026
- Jul 17, 2024
How other firms rate TNGX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| William Blair | Outperform | Oct 16, 2026 | |
| Jefferies | Buy | $60 | Jun 26, 2026 |
| Wolfe Research | Outperform | Jun 8, 2026 | |
| Piper Sandler | Neutral | $24 | May 15, 2026 |
| Canaccord Genuity | Buy | $30 | Apr 3, 2026 |
| Mizuho | Outperform | $19 | Feb 23, 2026 |
Questions about Jefferies and TNGX
- What is Jefferies's price target for TNGX?
- Jefferies's latest stated price target for Tango Therapeutics Inc. (TNGX) is $60, from its action on Jun 26, 2026.
- What is Jefferies's rating on TNGX?
- Jefferies rates TNGX Buy, a bullish rating, as of Jun 26, 2026.
- When did Jefferies last change its view on TNGX?
- On Jun 26, 2026, Jefferies upgrades to Buy from Hold, price target $60.
- How does Jefferies's TNGX target compare with other analysts?
- Across 4 firms with a TNGX price target in the last 12 months, the median target is $27. Jefferies's $60 is 122% above that.
More TNGX rating histories
All Jefferies ratingsTNGX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.